GlaxoSmithKline (GSK) announced a joint venture in China for the manufacture and distribution of vaccines in the region. This was the second such alliance for GSK this year in that country. In June, the company had signed an agreement with a Chinese biotech company to develop and manufacture flu vaccines.

Western drugmakers are stepping up the hunt for emerging market "tigers" in India.

Salix Pharmaceuticals Inc. said it is licensing drug delivery technology from Lupin Ltd. of India.

Major pharmaceutical companies see generics as a bridge to the future

MOST PHARMACEUTICAL innovators treat patent expiry like a terminal disease and the generics business as a sort of hospice where dying products ease into commodity oblivion, but recent deals and acquisitions suggest growing faith in an afterlife of emerging markets.